Lorde Says MDMA Therapy ‘Changed the Game’ on Her Stage Fright
8 Articles
8 Articles
Lorde Credits MDMA For Helping Her Get Over Her ‘Horrific Stage Fright’
Lorde, at this point, is a veteran performer. For a long time before she reached that level, though, she didn’t always thrive on stage as she dealt with some anxiety. On The Late Show With Stephen Colbert yesterday (June 24), though, she explained to the host how she got over it. Lorde told Colbert that she had the “truly the most horrific stage fright” since she was doing community theater performances at about five years old. Colbert asked how…
Lorde Says MDMA Therapy ‘Changed the Game’ on Her Stage Fright
Lorde is opening up about how MDMA therapy helped her overcome debilitating stage fright, crediting the treatment with changing her relationship with live performance entirely. During an appearance on The Late Show With Stephen Colbert, the pop star candidly discussed how she once suffered from “truly the most horrific stage fright” that dated back to her early childhood in community theatre. When Colbert asked how she got past it, Lorde didn’…
Lorde dubs MDMA her cure for stage fright
Lorde has been nabbing headlines left and right in promoting her upcoming album Virgin – take this Rolling Stone interview, for instance. Well here's another one: Lorde appeared on Stephen Colbert's late night program on June 24th, where she praised MDMA (or ecstasy) for curing her stage fright.The New Zealander claims "since [she] was like five, doing community theater," she "had truly the most horrific stage fright." The antidote? "MDMA therap…
Lorde Says MDMA Cured Her Stage Fright
Lorde will release her new album Virgin in just a couple of days. After streaming the album in full for fans earlier this week at Brooklyn’s Baby’s All Right (the same venue she name-dropped on lead single “What Was That”), she stopped by for an interview on The Late Show With Stephen Colbert. She didn’t perform, but she did talk about how her approach to performing has changed, thanks to help from guided MDMA therapy.
New Zealand announced Wednesday, June 18, allowing the medical use of psilocybine, which is present in some hallucinogenic fungi. A promising treatment for patients with depression and who have not responded to more conventional treatments. New Zealand announced Wednesday, June 18, that it has given its green light to the medical use of psilocybine, a compound naturally present in some hallucinogenic fungi, in the hope of fighting depression.
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
To view factuality data please Upgrade to Premium